AMDA Pocket Guidelines

Dementia Depression Delirium

AMDA GUIDELINES App Bundle brought to you courtesy of AMDA and Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512442

Contents of this Issue

Navigation

Page 9 of 53

Delirium 10 Key Points ➤ Delirium is a medical emergency – it may be the only manifestation of a life-threatening illness. ➤ Delirium is missed in 60% of cases. 2 ➤ The prevalence and incidence of delirium in post-acute/long-term care (PALTC) is 14% and 20-22% respectively. Up to 4 out of 5 persons will have delirium at the time of death. 3 ➤ Delirium that begins in hospital can continue for weeks to months. 4 ➤ Patients with delirium have a higher risk of dying – risk ratio (RR) of 4.9 in PALTC, and RR of 2 after a stroke or 5.4 if there is also a diagnosis of dementia. 2 ➤ Delirium can also lead to long-term functional decline, cognitive impairment, permanent nursing home placement, and increased costs. 2 ➤ Delirium superimposed on dementia tends to last longer and is associated with accelerated cognitive and functional decline, recurrent and longer hospitalizations, nursing home placement and death. 5 ➤ At the onset of any changes in mental status from baseline a validated delirium screening assessment should be performed. The Confusion Assessment Method (CAM) is included in the MDS 3.0. ➤ Delirium is preventable in 30-40% of cases. Since delirium occurs as a result of the interaction of multiple predisposing and precipitating risk factors, a multi-component non-pharmacologic approach for primary prevention is most effective. 2 ➤ Antipsychotics do not prevent delirium, shorten the duration, or reduce the severity of delirium. They have anticholinergic adverse effects and increase the risk for death when used for delirium in patients with pre-existing dementia. 6

Articles in this issue

view archives of AMDA Pocket Guidelines - Dementia Depression Delirium